Moreover, MAO A and MAO B inhibitors were found to decrease the glioma progression [17,45,46], supporting the hypothesis of a critical role played by MAOs in mediating oncogenesis in high-grade gliomas [46]. The gene discussed is MAOB; the disease is glioma.